European Commission approves pharma trio’s Ranivisio by John Pinching | Aug 30, 2022 | News | 0 Therapy is a biosimilar of Lucentis which treats several serious retinal diseases across the European Union Read More
NICE nod for Novartis’ Luxturna by Anna Smith | Sep 4, 2019 | News | 0 The treatment has been approved for RPE65-mediated inherited retinal dystrophies. Read More